M Karst, J Halpern, M Bernateck… - Cephalalgia, 2011 - cep.sagepub.com ... 5. Hintzen A and Passie T. The pharmacology of LSD. Oxford: Oxford University Press, 2010. 6. Karst M, Halpern JH, Bernateck M and Passie T. The non-hallucinogenic 2-bromo-lysergic aciddiethylamide Cephalalgia 31(5) 635–636 ! ...Lysergicaciddiethylamide (LSD-25). XVIII. ... Related articles - All 2 versions
[HTML] from plos.orgJ Dubois… - PLoS biology, 2011 - dx.plos.org ... doi:10.1371/journal.pbio.1001056.t001. Box 1. Selected Case Reports. Lysergicaciddiethylamide (LSD). ... Find this article online; Kawasaki A, Purvin V. A (1996) Persistent palinopsia following ingestion of lysergicaciddiethylamide (LSD). Arch Ophthalmol 114: 47. ... Cited by 1 - Related articles - Cached - All 6 versions
C Kremer, A Paulke, C Wunder… - Forensic Science …, 2011 - Elsevier ... Abbreviations: LSA, lysergicacid amide; LSD, lysergicaciddiethylamide. Article Outline. ... Effects are different from the anticipated lysergicaciddiethylamide (LSD)-like experience, although chemical structures of LSA and LSD are similar to each other. ...
[HTML] from brainblogger.comJ Gibson - Headache, 2011 - brainblogger.com ... treatments are available and effective for certain types of headache. The most alarming headache treatment option to emerge is the use of lysergicaciddiethylamide (LSD) and psilocybin (a hallucinogen derived from mushrooms). ... Related articles - Cached
O Johnson, J Becnel… - Neuroscience, 2011 - Elsevier ... The 5-HT 2 receptors are a primary target of classical hallucinogenic drugs like lysergicacid diethylamide, and couple to the G q signaling pathway and activation of 4 phospholipase-C . The 5-HT 2 receptor family as a whole is expressed widely throughout the CNS, and ...